VNY

Thuốc thú y Trung ương I ·UPCOM ·2026Q1

▲▲ Improving positively

Operating efficiency is improving Net margin 7.88%, +4.40pp YoY
Price
3,700
Latest close
29 May 2026
P/E 6.73x
P/B 0.54x
EPS 550
BVPS 6,813
ROE 8.4%
ROA 5.6%
Profit Margin 7.9%
Asset Turnover 0.71x
Equity Mult. 1.49x

TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity

What Is Changing

On a TTM 2026Q1 basis, VNY has not accelerated revenue sharply, but profitability is improving visibly — profit is at an all-time high. Profit growth is driven mainly by better operations rather than scale expansion — a foundation that tends to be more durable.

TTM REVENUE
VND 113bn
+4.2%YoY
NET MARGIN
7.88%
+4.4ppYoY
TTM NET PROFIT
VND 9bn
+136.0%YoY
Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23
Revenue 24.5 32.0 30.7 26.1 22.9 33.4 23.0 29.5 24.3 26.6 22.4 21.4
Growth -23% +4% +18% +14% -32% +45% -22% +22% -9% +18% +5%
Net Income 1.1 4.3 1.1 2.5 0.6 1.7 0.6 0.9 0.2 1.8 0.5 0.5
Net Margin 4.35% 13.34% 3.55% 9.58% 2.59% 5.13% 2.64% 2.95% 0.94% 6.68% 2.38% 2.28%

Drivers of VNY's profit

TTM

Net profit attributable to parent increased vs last year, mainly helped by lower selling expenses. Supporting and offsetting drivers:

Selling expenses ↓ 3.4bn
Other profit ↑ 1.5bn
Gross profit ↑ 1.0bn
Tax ↑ 1.2bn
TTM

Net profit attributable to parent increased vs prior quarter, mainly helped by lower selling expenses. Supporting and offsetting drivers:

Selling expenses ↓ 0.4bn
Gross profit ↑ 0.3bn
Financial income ↑ 0.2bn
Finance costs ↓ 0.1bn
Administrative expenses ↑ 0.2bn
Tax ↑ 0.1bn

Financial Highlights

Detailed analysis of each financial dimension

ROE = Profit Margin × Asset Turnover × Equity Multiplier

2025Q1 3.8% = 3.5% × 0.71 × 1.53
2026Q1 8.4% = 7.9% × 0.71 × 1.49

ROE rose from 3.8% to 8.4% — mainly driven by net margin, despite leverage moving in the opposite direction.

Net margin: 7.9% +4.4pp Asset turnover: 0.71x +0.00x Leverage: 1.49x -0.04x

Is the profit sustainable?

Margins are improving and earnings quality is solid — a durable foundation for ROE.

very positive positive stable watch under pressure

What is driving the margin?

Net margin expanded to 7.88%, rising 4.4pp. Core operating signals are improving as SG&A / Revenue fell 4.0pp are enough to offset pressure from Gross margin fell 0.1pp (with additional support from Other profit / Revenue rose 1.3pp and Net financial result / Revenue rose 0.3pp).

Margin improves from both core operations and non-core items — the core foundation is positive, but the sustainability of non-core contributions needs monitoring.

Profitability trend

Net Margin 7.88% +4.4pp
Gross Margin 25.31% −0.1pp
SG&A / Revenue 17.50% −4.0pp

TTM YoY · 2025Q1 -> 2026Q1

Is capital being used efficiently?

Return on capital rose, but cash cycle lengthened by 15.8 days — working capital needs watching.

Is capital being deployed efficiently?

ROIC expanded to 7.99%, rising 4.3pp. That translates to 7.99 in after-tax operating profit for every 100 units of operating capital. The main driver is NOPAT margin rose 3.3pp, with capital turnover broadly stable; with invested capital holding roughly steady.

NOPAT margin expansion has lifted ROIC above the deposit-rate threshold but below typical cost of equity — more same-direction periods are needed to confirm a structural shift.

CAPITAL EFFICIENCY TREND

TTM YoY · 2025Q1 -> 2026Q1

ROIC 7.99% +4.3pp
NOPAT Margin 6.26% +3.3pp
Capital Turnover 1.28x +0.02x
Average Invested Capital 88.8bn +2.1bn

Balance Sheet

ROIC is improving — the asset structure below shows how capital is being allocated. Balance sheet is exceptionally sound — liabilities at 0.49x equity, with a net cash position equivalent to 0.19x equity.

Inventory ended the period at 18.8bn, roughly 11.5% of total assets.

Over the last 12 months, working capital absorbed 1.5bn of cash, mainly because of higher receivables and lower payables. Part of that drag was offset by lower inventories.

Working Capital Drivers

TTM YoY · 2025Q1 -> 2026Q1

Receivables increased → lower CFO: −5.5bn
Inventories decreased → higher CFO: +8.0bn
Payables decreased → lower CFO: −4.0bn

Working Capital Efficiency

The inventory build-up noted above is reflected in a longer cash cycle. Cash conversion cycle lengthened by 15.8 days versus the same period last year. The main moves came from DIO fell 7.5 days, DSO rose 15.7 days, and DPO fell 7.7 days.

Working capital cycle lengthened mainly due to slower receivables collection — receivables quality needs monitoring.

Watchpoints

Cash conversion cycle is lengthening

CCC is up by +15.8 days, indicating weaker working-capital turnover versus the prior year.

Receivables collection is slowing

DSO increased by +15.7 days, pointing to slower receivables turnover.

Working Capital Efficiency

TTM YoY · 2025Q1 -> 2026Q1

Receivables 47.9 days +15.7 days
Inventory 93.8 days −7.5 days
Payables 99.9 days −7.7 days
Cash Conversion Cycle 41.8 days +15.8 days

Is financial risk significant?

Financial risk is low — the company has net cash and CFO reached 11.3bn.

Leverage & Liquidity

Leverage looks fairly comfortable, with net debt / equity at -0.19x and interest coverage at 14.75x.

At present, cash equals 281.4% of debt and total debt stands at 11.8bn.

Leverage and liquidity trend

Net Debt / Equity -0.19x −0.06x
Interest Coverage 14.75x +9.36x
Cash / Debt 281.4% +66.1pp
Short-term Debt / Total Debt
CFO / NI 1.09x +0.58x

TTM YoY · 2025Q1 -> 2026Q1

Cash Flow

With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 11.3bn in 2025, against investing cash flow of -1.2bn.

Post-investment cash flow was positive +10.1bn. Financing cash flow was positive 0.0bn.

CFO / net income was 1.09x.

After spending +2.7bn on fixed-asset investment, the business generated trailing free cash flow of +7.0bn.

Cash Conversion

TTM Cash Conversion · 2025Q1 -> 2026Q1

CFO TTM 9.7bn +7.8bn
Cash Capex 2.7bn +1.1bn
FCF TTM +7.0bn +6.7bn

Investment Takeaway

The business is heading the right way, but the current picture is still at partial confirmation — not yet a fully clean case. The positive points have clearly improved, showing the operating base is better than before. The brighter spot is operating efficiency, with net margin improving 4.4 pp. The next item to monitor is the earnings mix, when non-core contribution is 20.5%.

Improvement: operating efficiency is getting better, with trailing-12M net margin at 7.88% after expanding 4.4pp versus the same period last year.

Watchpoint: cash flow is currently keeping pace with accounting earnings, with CFO / net income at 1.09x. Even so, net financial result still accounts for 20.5% of PBT, so the earnings mix still needs monitoring.

Statement Data

Item 2025 2024 2023 2022
Net Revenue
111.7 109.1 94.3 138.6
Cost of Goods Sold
83.2 81.9 70.9 111.4
Gross Profit
28.5 27.2 23.4 27.2
Financial Expenses
0.7 0.9 0.7 2.0
Selling Expenses
10.2 12.8 11.8 12.8
General and Administrative Expenses
9.8 9.9 9.0 9.3
Operating Profit
8.5 4.3 2.6 3.8
Profit Before Tax
10.8 5.1 4.3 6.2
Net Income
8.5 3.8 3.4 5.6
Profit Attributable to Parent
8.5 3.8 3.4 5.6
Earnings per Share
508.00 220.00 211.00 393.00

Explore Other Stocks In The Same Sector

DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.